InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Baird Medical Investment Holdings Ltd

BDMD Clue Score22
Cayman Islands Fiscal year ends December CIK 0001982444
$0.75 -2.66% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.75 −52.26% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 1 Oct 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2022Revenue35.1Operating income13.6Net income12.8EPS, diluted0.49Fiscal year 2023Revenue31.5 −10.4%Operating income11.9Net income10.5 −17.4%EPS, diluted0.51 +4.1%Fiscal year 2024Revenue37.0 +17.7%Operating income15.3Net income12.5 +18.1%EPS, diluted0.57 +11.8%Fiscal year 2025Revenue22.5 −39.2%Operating income−25.6Net income−27.3 −319.0%EPS, diluted−0.98 −271.9%
FY2022FY2023FY2024FY2025
Revenue 35.1 31.5 37.0 22.5
Growth −10.4% +17.7% −39.2%
Operating income 13.6 11.9 15.3 −25.6
Net income 12.8 10.5 12.5 −27.3
Growth −17.4% +18.1% −319.0%
EPS, diluted 0.49 0.51 0.57 −0.98
Growth +4.1% +11.8% −271.9%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2022Gross margin79.9%Operating margin38.8%Net margin36.4%Free cash flow margin−15.5%Fiscal year 2023Gross margin86.6%Operating margin37.7%Net margin33.5%Free cash flow margin−11.6%Fiscal year 2024Gross margin88.2%Operating margin41.4%Net margin33.6%Free cash flow margin−24.8%Fiscal year 2025Gross margin83.8%Operating margin−113.7%Net margin−121.0%Free cash flow margin−6.2%
FY2022FY2023FY2024FY2025
Gross margin 79.9% 86.6% 88.2% 83.8%
Operating margin 38.8% 37.7% 41.4% −113.7%
Net margin 36.4% 33.5% 33.6% −121.0%
Free cash flow margin −15.5% −11.6% −24.8% −6.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow0.5Capital expenditure−5.9Free cash flow−5.4Fiscal year 2023Operating cash flow−1.0Capital expenditure−2.6Free cash flow−3.7Fiscal year 2024Operating cash flow−6.3Capital expenditure−2.9Free cash flow−9.2Fiscal year 2025Operating cash flow−1.3Capital expenditure−0.0Free cash flow−1.4
FY2022FY2023FY2024FY2025
Operating cash flow 0.5 −1.0 −6.3 −1.3
Capital expenditure −5.9 −2.6 −2.9 −0.0
Free cash flow −5.4 −3.7 −9.2 −1.4
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2022Cash1.7Shareholders’ equity25.8Fiscal year 2023Cash1.5Total debt2.4Net cash (debt)−0.9Shareholders’ equity35.8Debt to equity0.07Fiscal year 2024Cash3.0Total debt4.3Net cash (debt)−1.3Shareholders’ equity39.7Debt to equity0.11Fiscal year 2025Cash0.2Total debt8.7Net cash (debt)−8.5Shareholders’ equity31.4Debt to equity0.28
FY2022FY2023FY2024FY2025
Cash 1.7 1.5 3.0 0.2
Total debt n/a 2.4 4.3 8.7
Net cash (debt) n/a −0.9 −1.3 −8.5
Shareholders’ equity 25.8 35.8 39.7 31.4
Debt to equity n/a 0.07 0.11 0.28

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
1.7 1.5 3.0 0.2
n/a 31.1 46.6 42.5
n/a 1.1 1.3 1.1
n/a 6.1 7.1 6.4
n/a 0.1 0.1 0.1
n/a 56.7 78.0 69.7
Growth +37.5% −10.6%
Liabilities
n/a 0.8 0.9 2.6
n/a 1.6 3.4 6.1
calc n/a 2.4 4.3 8.7
n/a 21.0 38.2 38.5
Equity
n/a 14.4 26.8 −0.5
25.8 35.8 39.7 31.4
Growth +38.7% +10.9% −20.9%
Per share and net cash
calc n/a −0.9 −1.3 −8.5
n/a 29.4 35.7 41.0
calc n/a 1.22 1.11 0.77

Lines marked calc are worked out here from filed figures; point at one for how.